Recombinant Interleukin-2 in Patients Aged Younger Than 60 Years With Acute Myeloid Leukemia in First Complete Remission: Results From Cancer and Leukemia Group B 19808

BACKGROUND: Recombinant interleukin-2 (rIL-2) induces cellular cytotoxicity against leukemia blasts. Patients with acute myeloid leukemia (AML) in first complete remission (CR) may harbor minimal residual disease that is susceptible to rIL-2–activated effector cells. METHODS: In the Cancer and Leuke...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kolitz, Jonathan E., George, Stephen L., Benson, Don M., Maharry, Kati, Marcucci, Guido, Vij, Ravi, Powell, Bayard L., Allen, Steven L., DeAngelo, Daniel J., Shea, Thomas C., Stock, Wendy, Bakan, Courtney E., Hars, Vera, Hoke, Eva, Bloomfield, Clara D., Caligiuri, Michael A., Larson, Richard A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4139069/
https://ncbi.nlm.nih.gov/pubmed/24382782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28516
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados